Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Carlsson

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Journal of Neural Transmission (Vienna, Austria : 1996)|August 28, 1998
Rodent data and general hypothesis: antipsychotic action exerted through 5-Ht2A receptor antagonism is dependent on increased serotonergic toneP Martin, N Waters, C J Schmidt, et al.
Annual Review of Pharmacology and Toxicology|March 27, 2001
Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidenceA Carlsson, N Waters, S Holm-Waters, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|May 5, 1999
The 5-HT2A receptor antagonist M100907 is more effective in counteracting NMDA antagonist- than dopamine agonist-induced hyperactivity in miceM L Carlsson, P Martin, M Nilsson, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Journal of Neural Transmission (Vienna, Austria : 1996)|August 28, 1998
Rodent data and general hypothesis: antipsychotic action exerted through 5-Ht2A receptor antagonism is dependent on increased serotonergic toneP Martin, N Waters, C J Schmidt, et al.
Annual Review of Pharmacology and Toxicology|March 27, 2001
Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidenceA Carlsson, N Waters, S Holm-Waters, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|May 5, 1999
The 5-HT2A receptor antagonist M100907 is more effective in counteracting NMDA antagonist- than dopamine agonist-induced hyperactivity in miceM L Carlsson, P Martin, M Nilsson, et al.
Pageof 4